CAI Caris Life Sciences, Inc. - Common Stock
$15,18
Fiyat · May 20, 2026
Temel veriler itibarıyla May 8, 2026
52 Haftlık Aralık
$14–$42
3% of range
Analist Derecelendirmesi
STRONG BUY
17 analysts
Fiyat Hedefi
$28
+84% upside
P/E (TTM)
-8.4
ROE
-13.2%
Net Kâr Marjı
-8.4%
CAI Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$15.18
Piyasa Değeri
$7.62B
P/E (TTM)
-8.4
EPS (TTM)
$-3.22
Gelir (TTM)
$812M
Temettü Verimi
—
ROE
-13.2%
D/E Borç/Özsermaye
0.7
52 Haftlık Aralık
$14 – $43
CAI Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$812M
2023-12-31
→
2025-12-31
Hisse Başına Kâr
$-3.22
2023-12-31
→
2025-12-31
Serbest Nakit Akışı
$67M
2025-12-31
→
2025-12-31
Marjlar
-8.4%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
CAI
Akran Ortalaması
P/E (TTM)
-8.4
17.8
P/S (TTM) (F/S (TTM))
9.4
8.0
P/B (F/D)
13.2
3.2
EV / EBITDA
106.4
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
113.9
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
CAI
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
5.6%
—
Net Profit Margin (Net Kâr Marjı)
-8.4%
-23.3%
ROA
-9.3%
-25.0%
ROE
-13.2%
-29.4%
ROIC
4.7%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
CAI
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
0.7
78.7
Current Ratio (Cari Oran)
7.8
9.6
Quick Ratio (Cari Oran)
7.2
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
CAI
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
97.0%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
CAI
Akran Ortalaması
CAI Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
17 analist
- Güçlü Al 7 41,2%
- Al 7 41,2%
- Tut 3 17,6%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
13 analist · 2026-05-20
Medyan
$28.00
← Tüm hedeflerin altında
$15.18
Düşük
$21.00
Yüksek
$36.00
Medyan hedef
$28.00
+84,5%
Ortalama hedef
$28.00
+84,5%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-1.8%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $0.00 | $-0.02 | 0.02% |
| 31 Aralık 2025 | $0.28 | $0.03 | 0.25% |
| 30 Eylül 2025 | $0.08 | $-0.21 | 0.29% |
| 30 Haziran 2025 | $-7.97 | $-0.20 | -7.8% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| LEGN | — | — | — | — | — | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| CPRX | — | 13.9 | 19.8% | — | — | — |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
| ORKA | $1.48B | -3.3 | — | — | -25.9% | — |
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $812M | $412M | $306M | |
| R&D Expense | $102M | $114M | $117M | |
| SG&A Expense | $225M | $169M | $149M | |
| Operating Expenses | $767M | $669M | $626M | |
| Operating Income | $45M | $-257M | $-320M | |
| Other Non-op | $-21M | $-349.0K | $-13M | |
| Pretax Income | $-68M | $-282M | $-341M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-68M | $-282M | $-341M | |
| EPS (Basic) | $-3.22 | $-10.66 | $-13.24 | |
| EPS (Diluted) | $-3.22 | $-10.66 | $-13.24 | |
| Shares (Basic) | 167,205,616 | 35,496,832 | 34,942,691 | |
| Shares (Diluted) | 167,205,616 | 35,496,832 | 34,942,691 | |
| EBITDA | $68M | · | · |
Bilanço 28
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $796M | $64M | · | |
| Short-term Investments | $2M | $2M | · | |
| Receivables | $112M | $88M | · | |
| Prepaid Expense | $22M | $20M | · | |
| Other Current Assets | $2M | $7M | · | |
| Current Assets | $998M | $216M | · | |
| PP&E (Net) | $63M | $68M | · | |
| PP&E (Gross) | $304M | $296M | · | |
| Accum. Depreciation | $241M | $229M | · | |
| Goodwill | $19M | $19M | · | |
| Other Non-current Assets | $45M | $41M | · | |
| Total Assets | $1.13B | $344M | · | |
| Accounts Payable | $39M | $28M | · | |
| Accrued Liabilities | $88M | $78M | · | |
| Current Liabilities | $127M | $165M | · | |
| Capital Leases | $42M | $39M | · | |
| Other Non-current Liabilities | $42M | $44M | · | |
| Total Liabilities | $548M | $621M | · | |
| Long-term Debt | $378M | $373M | · | |
| Total Debt | $379M | · | · | |
| Common Stock | $283.0K | $38.0K | · | |
| Paid-in Capital | $3.14B | $0 | · | |
| Retained Earnings | $-2.55B | $-2.47B | · | |
| Treasury Stock | $17M | $330.0K | · | |
| AOCI | $936.0K | $210.0K | · | |
| Stockholders' Equity | $577M | $-2.50B | $-2.14B | |
| Liabilities + Equity | $1.13B | $344M | · | |
| Shares Outstanding | 282,526,097 | 35,842,319 | 35,297,278 |
Nakit Akışı 11
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $23M | $49M | $49M | |
| Stock-based Comp | $70M | $19M | $15M | |
| Other Non-cash | $59M | · | · | |
| Operating Cash Flow | $83M | $-245M | $-276M | |
| CapEx | $16M | $8M | $22M | |
| Investing Cash Flow | $-16M | $53M | $215M | |
| Stock Repurchased | $113.0K | $0 | $0 | |
| Net Stock Activity | $-113.0K | · | · | |
| Financing Cash Flow | $665M | $200M | $10M | |
| Net Change in Cash | $732M | $8M | $-51M | |
| Free Cash Flow | $67M | · | · |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | 5.6% | · | · | |
| Net Margin | -8.4% | · | · | |
| Pretax Margin | -8.4% | · | · | |
| EBITDA Margin | 8.3% | · | · | |
| ROA | -9.3% | · | · | |
| ROE | -13.2% | · | · | |
| ROIC | 4.7% | · | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.8 | · | · | |
| Quick Ratio | 7.2 | · | · | |
| Debt / Equity | 0.7 | · | · | |
| LT Debt / Equity | 0.7 | · | · |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 1.1 | · | · | |
| Receivables Turnover | 8.1 | · | · |
Büyüme Oranları 1
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 97.0% | 34.7% | · |
Değerleme (TTM) 14
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $812M | · | · | |
| Net Income TTM | $-68M | · | · | |
| Market Cap | $7.62B | · | · | |
| Enterprise Value | $7.20B | · | · | |
| P/E | -8.4 | · | · | |
| P/S | 9.4 | · | · | |
| P/B | 13.2 | · | · | |
| P / Tangible Book | 13.7 | · | · | |
| P / Cash Flow | 91.7 | · | · | |
| P / FCF | 113.9 | · | · | |
| EV / EBITDA | 106.4 | · | · | |
| EV / FCF | 107.7 | · | · | |
| EV / Revenue | 8.9 | · | · | |
| Earnings Yield | -11.9% | · | · |
Gelir Tablosu 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $216M | $293M | $217M | $181M | $121M | $130M | $102M | |
| R&D Expense | $31M | $32M | $22M | $25M | $23M | $27M | $28M | |
| SG&A Expense | $60M | $57M | $52M | $64M | $52M | $43M | $41M | |
| Operating Expenses | $211M | $204M | $184M | $199M | $179M | $167M | $162M | |
| Operating Income | $5M | $88M | $33M | $-18M | $-58M | $-37M | $-61M | |
| Other Non-op | $49.0K | $-2M | $-89.0K | $-18M | $-17.0K | $-26.0K | $37.0K | |
| Pretax Income | $-644.0K | $82M | $24M | $-72M | $-103M | $-37M | $-68M | |
| Income Tax | $-134.0K | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-510.0K | $82M | $24M | $-72M | $-103M | $-37M | $-68M | |
| EPS (Basic) | $0.00 | $1.61 | $0.09 | $-7.97 | $-3.57 | $-1.74 | $-2.59 | |
| EPS (Diluted) | $0.00 | $1.61 | $0.08 | $-7.97 | $-3.57 | $-1.74 | $-2.59 | |
| Shares (Basic) | 282,562,013 | 38,757,943 | 282,099,073 | 64,918,988 | 35,623,042 | 53,905 | 35,643,589 | |
| Shares (Diluted) | 282,562,013 | 38,757,943 | 297,211,838 | 64,918,988 | 35,623,042 | 53,905 | 35,643,589 | |
| EBITDA | $10M | · | $38M | $-12M | · | · | · |
Bilanço 28
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $820M | $796M | $753M | $719M | · | $64M | · | |
| Short-term Investments | $2M | $2M | $2M | $2M | · | $2M | · | |
| Receivables | $91M | $112M | $27M | $51M | · | $88M | · | |
| Prepaid Expense | $24M | $22M | $21M | $19M | · | $20M | · | |
| Other Current Assets | $4M | $2M | $3M | $3M | · | $7M | · | |
| Current Assets | $1.01B | $998M | $854M | $833M | · | $216M | · | |
| PP&E (Net) | $83M | $63M | $64M | $61M | · | $68M | · | |
| PP&E (Gross) | $328M | $304M | $304M | $303M | · | $296M | · | |
| Accum. Depreciation | $246M | $241M | $240M | $242M | · | $229M | · | |
| Goodwill | $19M | $19M | $19M | $19M | · | $19M | · | |
| Other Non-current Assets | $46M | $45M | $47M | $41M | · | $41M | · | |
| Total Assets | $1.16B | $1.13B | $985M | $955M | · | $344M | · | |
| Accounts Payable | $70M | $39M | $29M | $29M | · | $28M | · | |
| Accrued Liabilities | $74M | $88M | $57M | $61M | · | $78M | · | |
| Current Liabilities | $144M | $127M | $86M | $90M | · | $165M | · | |
| Capital Leases | $44M | $42M | $44M | $38M | · | $39M | · | |
| Other Non-current Liabilities | $44M | $42M | $44M | $38M | · | $44M | · | |
| Total Liabilities | $569M | $548M | $506M | $502M | · | $621M | · | |
| Long-term Debt | $381M | $378M | $376M | $373M | · | $373M | · | |
| Total Debt | $382M | · | $376M | $374M | · | · | · | |
| Common Stock | $284.0K | $283.0K | $283.0K | $282.0K | · | $38.0K | · | |
| Paid-in Capital | $3.16B | $3.14B | $3.12B | $3.12B | · | $0 | · | |
| Retained Earnings | $-2.55B | $-2.55B | $-2.63B | $-2.66B | · | $-2.47B | · | |
| Treasury Stock | $17M | $17M | $17M | $17M | · | $330.0K | · | |
| AOCI | $893.0K | $936.0K | $748.0K | $669.0K | · | $210.0K | · | |
| Stockholders' Equity | $593M | $577M | $478M | $453M | · | $-2.50B | · | |
| Liabilities + Equity | $1.16B | $1.13B | $985M | $955M | · | $344M | · | |
| Shares Outstanding | 282,650,723 | 282,526,097 | 282,103,259 | 281,090,538 | · | 36,504,319 | · |
Nakit Akışı 11
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $4M | $5M | $6M | $7M | $9M | $10M | |
| Stock-based Comp | $16M | $13M | $14M | $28M | $15M | $5M | $5M | |
| Other Non-cash | $12M | · | · | · | · | · | · | |
| Operating Cash Flow | $33M | $45M | $62M | $7M | $-31M | $-39M | $-69M | |
| CapEx | $10M | $5M | $7M | $1M | $3M | $2M | $2M | |
| Investing Cash Flow | $-10M | $-5M | $-7M | $-1M | $-3M | $-2M | $-2M | |
| Stock Repurchased | $0 | $91.0K | $0 | $0 | $22.0K | $0 | $0 | |
| Net Stock Activity | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $824.0K | $3M | $-21M | $681M | $1M | $226.0K | $87.0K | |
| Net Change in Cash | $23M | $43M | $34M | $687M | $-33M | $-41M | $-71M | |
| Free Cash Flow | $23M | · | · | · | · | · | · |
Kârlılık 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.4% | · | 15.0% | -9.9% | · | · | · | |
| Net Margin | -0.24% | · | 11.2% | -39.6% | · | · | · | |
| Pretax Margin | -0.30% | · | 11.2% | -39.6% | · | · | · | |
| EBITDA Margin | 4.8% | · | 17.3% | -6.4% | · | · | · | |
| ROA | -0.09% | · | 4.9% | -15.0% | · | · | · | |
| ROE | -0.17% | · | 10.2% | -31.7% | · | · | · | |
| ROIC | 0.43% | · | 3.8% | -2.2% | · | · | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | · | 9.9 | 9.2 | · | · | · | |
| Quick Ratio | 6.3 | · | 9.1 | 8.6 | · | · | · | |
| Debt / Equity | 0.6 | · | 0.8 | 0.8 | · | · | · | |
| LT Debt / Equity | 0.6 | · | 0.8 | 0.8 | · | · | · |
Verimlilik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | · | 0.4 | 0.4 | · | · | · | |
| Receivables Turnover | 4.8 | · | 16.2 | 7.1 | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $735M | · | · | · | · | · | · | |
| Net Income TTM | $-151M | · | · | · | · | · | · | |
| Market Cap | $5.05B | · | $8.53B | $7.51B | · | · | · | |
| Enterprise Value | $4.61B | · | $8.15B | $7.16B | · | · | · | |
| P/E | -1.6 | · | · | · | · | · | · | |
| P/S | 6.9 | · | · | · | · | · | · | |
| P/B | 8.5 | · | 17.8 | 16.6 | · | · | · | |
| P / Tangible Book | 8.8 | · | 18.6 | 17.3 | · | · | · | |
| P / Cash Flow | 153.7 | · | · | · | · | · | · | |
| P / FCF | 224.3 | · | · | · | · | · | · | |
| EV / EBITDA | 445.8 | · | 217.2 | -618.1 | · | · | · | |
| EV / FCF | 204.7 | · | · | · | · | · | · | |
| EV / Revenue | 6.3 | · | · | · | · | · | · | |
| Earnings Yield | -64.1% | · | · | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Gelir | $812M | $412M | $306M |
| Faaliyet Kâr Marjı % | 5.6% | — | — |
| Net Gelir | $-68M | $-282M | $-341M |
| Seyreltilmiş Hisse Başı Kâr | $-3.22 | $-10.66 | $-13.24 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Borç / Öz Sermaye | 0.7 | — | — |
| Cari Oran | 7.8 | — | — |
| Cari Oran | 7.2 | — | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Serbest Nakit Akışı | $67M | — | — |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.